We keep meeting the same problem in different rooms. A mother who cannot get an explanation for a heart that failed after a product she was told was local and brief. Another otherwise healthy family member or friend with a raging cancer diagnosis that occurred months after receiving the mRNA vaccination. A clinician who knows something changed in the tempo of disease and is punished for saying so out loud. And behind all of that sits a platform still being sold — first as a pandemic necessity, then as a flu shot, now as personalized cancer care — as if changing the brochure could ever change a flawed platform and the dangerous, harmful reprogramming and destruction it produces.
We did not come to this work to argue with slogans. We came to it because care is supposed to start with the patient in front of you: what is wrong in that person, and what would actually correct it. This technology works the other way. A sequence is written in software. The RNA is chemically altered so the body’s early-warning sensors are less likely to see it. It is packaged into a lipid particle that does not remain in the arm. Cells are then ordered to manufacture a protein — and the protein they are ordered to make is not a neutral marker. It is a destructive ligand. In mass-used products, that protein is spike: it injures the endothelium, drives inflammatory injury, and has been recovered from damaged tissue. It also initiates proto-oncogenic signaling. It does not merely sit in the cell as an antigen. It stresses transcription and restraint pathways, pushes proliferative programs, and accelerates a damaged cell toward malignancy. What the cell actually prints is not even guaranteed to stop at the intended sequence. Off-target polypeptides can also be made. The platform treats that as acceptable, gives the next dose, and now looks for a new market so the same method can continue.
The title is not theater. Synthetic mRNA vaccine technology is a threat large enough to be described as a threat to human extinction because the instructions cannot be retrieved and the scale is already planetary. That is not a claim that the species has ended. These injections do not spread from person to person. It is a claim that policy is still issuing an irreversible product, and that continuing to issue it — into influenza season, into oncology — is how a platform becomes a condition of the population. Withdraw it.
The short film is the same case in sixty seconds. Watch it, then stay with the file.
Years ago, demands for the complete withdrawal of these products from the market were raised in the Senate and the European Parliament. The public record of physicians, officials, and organizations who have asked for the same is already long. This month, a formal request was sent to federal health agencies to withdraw the new mRNA influenza license, citing the FDA’s own trial data. This is not a new controversy. It is the same product asking for another season.
If the answer to a failed mass campaign is another mRNA shot, the emergency was never the point. The chassis was. We will not accept oncology as the next excuse to keep it. The nucleoside is the same. The particle is the same. The software-altered file is the same. COVID was how it entered the healthy. Influenza is how it stays ordinary. Cancer is how it is baptized as precision.
Revoke the COVID-19 authorizations. Stop shipment of the influenza product. Refuse every oncology indication built on this system. There is no safe half.
We do not need another working group to know that cardiac injury after these products is not a communications problem. We have had to talk about risk-stratifying people for cardiac arrest who never had a warning visit. That sentence should have ended the product. Instead, it was managed.
The withdrawal reviews did what agencies would not: they put the death-report volume next to the historical recall standard and showed that any earlier vaccine would have been pulled at a fraction of this signal. Effectiveness that inverted after the early window was treated as a variant problem. A product that was never as clean as advertised was treated as a footnote in the manufacturing process. Autopsy work was suppressed, withdrawn, and litigated because the conclusion was removal. Patients did not stop presenting while that fight went on. Families did not stop calling. A journal dispute is not a safety finding. It is evidence that the finding was not wanted.
The phrase is ugly because the tempo is ugly. People without risk of developing cancer are now faced with a furious battle. Tumors that had a clock began to ignore it. Presentations in people who should have had time. Stage that jumped. Recurrence that did not wait. We will not pretend that is a complete census of every malignancy in the country. We will not pretend it is nothing. Clinicians reached for a word because the old words — indolent, expected, watchful — stopped fitting what they were seeing.
The molecular account is not mystical. This platform asks cells to run a synthetic instruction they did not evolve to run. It loads innate and inflammatory programs. In patients we have profiled after these injections, we have observed transcriptomic disruption, ribosomal and surveillance stress, oncogene-linked activation, and a loss of the restraint that prevents a damaged cell from becoming malignant. That is mutation pressure. That is proto-oncogenic signaling. When suppressor tone falls, and proliferative signaling rises, you do not get a quieter cancer. You get a faster one.
Figure 1 is that sequence without the euphemism: one construct, three markets, and the pressure that follows.
That is what turbo cancer is: not a new species of cells and tumor, a known disease driven harder. A sentinel case of aggressive, rapidly advancing malignancy after an mRNA series is already in the record, with dysregulation we could not honestly call coincidence. One case does not close a national question. It is more than enough to stop dosing the next million people while you pretend the question is closed.
You do not treat cancer by adding mutational load to the host. You do not sequence a tumor, let software rank a cassette, and call that patient-specific design. Patient-specific work reads the biology and answers it downstream of the genome. The oncology mRNA push does the opposite. It keeps the same particle and sells the ranking as precision. Bar that indication. Do not launder a failed public health product with a melanoma brochure.
This same dysregulated signaling initiates a wide range of additional diseases, including autoimmune disorders, neurodegenerative conditions, cardiovascular and neurological disease, multisystem failures, and other hyperinflammatory, tissue-destructive pathologies.
We have no interest in a list that sounds like a poster. We are talking about the woman whose myocardium is no longer the muscle she brought into the clinic, and the fact that no subsequent guidance document will restore it. We are talking about the immune system that has already seen a protein it was ordered to make — and, in some people, proteins that were never on the insert — and will not forget them because a regulator changed tone. We are talking about the weeks a tumor used while a custom lot was being written, weeks that do not come back. We are talking about genomic stress and proto-oncogenic drive, which are not seasonal campaigns. You do not un-inject them in April.
The first instruction has already been given. That part of the story is finished. What is not finished is whether we keep giving it. Withdrawal is not a metaphor for caution. It is the refusal to issue the next dose of a product for which the last dose cannot be retrieved.
Revoke the COVID-19 mRNA authorizations.
Withdraw the mRNA influenza license and stop distribution.
Refuse oncology expansion on this chassis.
Quarantine what is left.
Stop putting a genetic product into people with active malignancy and into people whose surveillance already shows oncogenic strain.
Never reduce it to therapy, never confine it to cancer, and never wait until extinction. Public policy demands this technology be withdrawn immediately!
https://johncatanzaro.substack.com/p/neo7bioscience-fda-petition-statement
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.